Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension
Clinical trial NCT02169752 · TERMINATED
Trial details
- NCT number
- NCT02169752
- Sponsor
- National Jewish Health
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2017-05-25
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.